Lupus and inflammatory bowel disease share a common set of microbiome features distinct from other autoimmune disorders

2024-9-18

Response to: Correspondence on ‘EULAR recommendations for the management of systemic lupus erythematosus: 2023 update’ by Fanouriakis<i>et al</i>

2024-9-18

Therapeutic interception in individuals at risk of rheumatoid arthritis to prevent clinically impactful disease

2024-9-6

Protein kinase R is highly expressed in dermatomyositis and promotes interferon-beta-induced muscle damage

2024-9-5

Correspondence on ‘EULAR recommendations for the management of systemic lupus erythematosus: 2023 update’ by Fanouriakis<i>et al</i>

2024-9-5

Generation of cytotoxic aptamers specifically targeting fibroblast-like synoviocytes by CSCT-SELEX for treatment of rheumatoid arthritis

2024-9-4

Predicting rapid progression in knee osteoarthritis: a novel and interpretable automated machine learning approach, with specific focus on young patients and early disease

2024-9-4

More than meets the eye

2024-8-31

Serum from patients with idiopathic inflammatory myopathy induces skeletal muscle weakness

2024-8-28

Correspondence on ‘Risk of cardiovascular disease with high-dose versus low-dose use of non-steroidal anti-inflammatory drugs in ankylosing spondylitis’ by Kim<i>et al</i>

2024-8-28

Relationship between serum urate and changes in dual-energy CT monosodium urate crystal volume over 1 year in people with gout: an individual participant data analysis

2024-8-21

Disease activity of rheumatoid arthritis and kidney function decline: a large prospective registry study

2024-8-21

Treatment of early oligoarticular psoriatic arthritis with apremilast: primary outcomes at week 16 from the FOREMOST randomised controlled trial

2024-8-20

Positive feedback loop PU.1-IL9 in Th9 promotes rheumatoid arthritis development

2024-8-20

Efficacy and safety of sequential therapy with subcutaneous belimumab and one cycle of rituximab in patients with systemic lupus erythematosus: the phase 3, randomised, placebo-controlled BLISS-BELIEVE study

2024-8-19

CD19-CAR T-cell therapy induces deep tissue depletion of B cells

2024-8-17

Plasma proteome profiling in giant cell arteritis

2024-8-17

SerpinA3N limits cartilage destruction in osteoarthritis by inhibiting macrophage-derived leucocyte elastase

2024-8-12

Mutilating arthropathy with skin nodules

2024-8-8

<i>Helicobacter pylori</i>upregulates PAD4 expression via stabilising HIF-1α to exacerbate rheumatoid arthritis

2024-8-6

From fibrositis to fibromyalgia to nociplastic pain: how rheumatology helped get us here and where do we go from here?

2024-8-6

Journey through discovery of 75 years glucocorticoids: evolution of our knowledge of glucocorticoid receptor mechanisms in rheumatic diseases

2024-8-6

Development of international consensus on a standardised image acquisition protocol for diagnostic evaluation of the sacroiliac joints by MRI: an ASAS–SPARTAN collaboration

2024-8-6

Rheumatoid arthritis patients harbour aberrant enteric bacteriophages with autoimmunity-provoking potential: a paired sibling study

2024-7-31

Multiorgan involvement and circulating IgG1 predict hypocomplementaemia in IgG4-related disease

2024-7-30

Mystery of hidden pearls: bursitis in the shoulder

2024-7-30

Association of rheumatoid factor, anti-citrullinated protein antibodies and shared epitope with clinical response to initial treatment in patients with early rheumatoid arthritis: data from a randomised controlled trial

2024-7-30

New WHO ACPA standard enables standardisation among anti-CCP2 assays, but not other ACPA assays using different antigens

2024-7-23

Altered CD8⁺T cell subpopulation in the bone marrow microenvironment of cynomolgus monkeys with spontaneous ankylosing spondylitis

2024-7-17

Racial variability in immune responses only partially explains differential systemic sclerosis disease severity

2024-7-17

Early identification of rheumatoid arthritis: does it induce treatment-related cost savings?

2024-7-17

Dysregulation of immune checkpoint molecules as a characteristic of autoimmune congenital heart block

2024-7-12

Itaconate is a metabolic regulator of bone formation in homeostasis and arthritis

2024-7-10

Low uveitis rates in patients with axial spondyloarthritis treated with bimekizumab: pooled results from phase 2b/3 trials

2024-7-8

Acod1-mediated inhibition of aerobic glycolysis suppresses osteoclast differentiation and attenuates bone erosion in arthritis

2024-7-4

Efficacy and safety of first-line biological DMARDs in rheumatoid arthritis patients with chronic kidney disease

2024-7-4

Olokizumab plus methotrexate: safety and efficacy over 106 weeks of treatment

2024-7-2

Haematopoietic stem cell-derived immune cells have reduced X chromosome inactivation skewing in systemic lupus erythematosus

2024-6-27

Clinical efficacy and autoantibody seroconversion with CD19-CAR T cell therapy in a patient with rheumatoid arthritis and coexisting myasthenia gravis

2024-6-27

Cardiac valve immune profiling in non-radiographic axial spondyloarthritis

2024-6-26

Pathological autoantibody internalisation in myositis

2024-6-20

EULAR recommendations for the involvement of patient research partners in rheumatology research: 2023 update

2024-6-14

CPPD disease presenting with acute arthritis of the first metatarsophalangeal joint

2024-6-13

Defects in B-lymphopoiesis and B-cell maturation underlie prolonged B-cell depletion in ANCA-associated vasculitis

2024-6-8

Safety and efficacy of tofacitinib for the treatment of patients with juvenile idiopathic arthritis: preliminary results of an open-label, long-term extension study

2024-6-7

Eng Meng Tan

2024-6-3

2023 EULAR classification criteria for hand osteoarthritis

2024-5-31

Association between premature vascular smooth muscle cells senescence and vascular inflammation in Takayasu’s arteritis

2024-5-30

Predictors for severe persisting pain in rheumatoid arthritis are associated with pain origin and appraisal of pain

2024-5-30

Factors associated with disease flare following SARS-CoV-2 vaccination in people with inflammatory rheumatic and musculoskeletal diseases: results from the physician-reported EULAR Coronavirus Vaccine (COVAX) Registry

2024-5-30